Pharmacological properties of proquazone.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001169:Arthritis, Experimental / Q000503:physiopathology; D004353:Drug Evaluation, Preclinical; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D007213:Indomethacin / Q000009:adverse effects / Q000494:pharmacology; D007249:Inflammation / Q000503:physiopathology; D011799:Quinazolines / Q000009:adverse effects / Q000494:pharmacology*; D051381:Rats
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011799:Quinazolines; D007213:Indomethacin